Cre recombinase
Cre recombinase is a tyrosine recombinase enzyme derived from the P1 bacteriophage. It is widely used in genetic engineering to carry out site-specific recombination events. The enzyme recognizes specific DNA sequences known as loxP sites and catalyzes the recombination between these sites. This system is commonly referred to as the Cre-Lox recombination system.
Structure and Function
Cre recombinase is a 38 kDa protein that functions as a homotetramer. Each monomer of Cre recombinase binds to a 34 base pair loxP site, which consists of two 13 base pair palindromic sequences flanking an 8 base pair asymmetric core sequence. The enzyme mediates recombination by cleaving the DNA at the loxP sites and rejoining the DNA strands in a new configuration.
Mechanism of Action
The recombination process involves several steps: 1. **Binding**: Cre recombinase binds to the loxP sites. 2. **Cleavage**: The enzyme introduces a double-strand break at the loxP sites. 3. **Strand Exchange**: The DNA strands are exchanged between the loxP sites. 4. **Ligation**: The DNA strands are re-ligated, resulting in a recombined DNA sequence.
Applications
Cre recombinase is extensively used in molecular biology and genetics for various applications, including:
- **Conditional Gene Knockout**: By flanking a gene of interest with loxP sites, researchers can use Cre recombinase to delete the gene in specific tissues or at specific developmental stages.
- **Gene Activation**: Cre recombinase can be used to activate gene expression by removing a stop sequence flanked by loxP sites.
- **Chromosomal Rearrangements**: The enzyme can induce inversions, deletions, and translocations of chromosomal segments.
Cre-Lox System in Research
The Cre-Lox system is a powerful tool in mouse genetics and has been used to create various transgenic mouse models to study gene function and disease mechanisms. By using tissue-specific or inducible promoters to drive Cre expression, researchers can achieve precise control over gene recombination events.
Advantages and Limitations
Advantages
- **Specificity**: The Cre-Lox system is highly specific, allowing for targeted genetic modifications.
- **Versatility**: It can be used for a wide range of genetic manipulations, including gene knockouts, knock-ins, and chromosomal rearrangements.
Limitations
- **Efficiency**: The efficiency of recombination can vary depending on the accessibility of loxP sites and the expression levels of Cre recombinase.
- **Off-target Effects**: Although rare, off-target recombination events can occur, leading to unintended genetic modifications.
See Also
References
External Links
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD